ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN INFLAMMATORY BOWEL-DISEASE AND COLLAGENOUS COLITIS - NO ASSOCIATION WITH LACTOFERRIN, BETA-GLUCURONIDASE, MYELOPEROXIDASE, OR PROTEINASE-3
P. Yang et al., ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN INFLAMMATORY BOWEL-DISEASE AND COLLAGENOUS COLITIS - NO ASSOCIATION WITH LACTOFERRIN, BETA-GLUCURONIDASE, MYELOPEROXIDASE, OR PROTEINASE-3, Inflammatory bowel diseases, 2(3), 1996, pp. 173-177
Perinuclear antineutrophil cytoplasmic antibodies (P-ANCA) occur frequ
ently in ulcerative colitis (UC) but not in Crohn's disease (CD). Thei
r pathogenetic importance is unknown, and studies of associated antige
ns have been inconsistent. Indirect immunofluorescence technique was u
sed to screen the occurrence of antineutrophil cytoplasmic antibodies
in 36 patients with UC, in 37 patients with CD, in 38 patients with co
llagenous colitis (CC), and in 190 controls. Enzyme immunoassays (EIAs
) were used to detect the target antigen(s) by using lactoferrin (Lf),
beta-glucuronidase (beta-Glc), myeloperoxidase (MPO), and proteinase
3 (PR3) as the substrates. P-ANCA was found in 23 (63.9%) of 36 of the
patients with UC, in two (5.4%) of 37 with CD, in four (10.5%) of 38
with CC, and in four (2.1%) of 190 of healthy controls. No case of cyt
oplasmic staining pattern (C-ANCA) was found. With EIA, P-ANCA in IBD
or CC was not found to be associated with reactivity to Lf, beta-Glc,
MPO, or PR3, which confirms findings reported by others. P-ANCA was fo
und in a higher frequency in UC than in CD or CC. The antigens of P-AN
CA remain unidentified.